ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,383.78
-0.39%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,412.715
-0.36%
Brent Oil
82.15
-0.36%
Bitcoin
70,022.20
-0.16%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Catalyst Biosciences Inc (CBIO)

  7. Catalyst Biosciences Inc (CBIO) News

Catalyst Biosciences (CBIO)

Catalyst Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBIO
DateTimeSourceHeadlineSymbolCompany
02/05/202423:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
01/05/202421:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202413:49Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202413:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202413:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
19/04/202421:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
09/04/202421:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
08/04/202423:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
05/04/202422:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
04/04/202422:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
03/04/202421:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
03/04/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
02/04/202422:35Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
01/04/202423:42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
26/03/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
26/03/202401:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
22/03/202400:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
22/03/202400:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
21/03/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
19/03/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
15/03/202421:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
14/02/202422:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
24/01/202422:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
19/01/202421:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
12/01/202421:01Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
15/12/202321:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
06/12/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
29/11/202321:01Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CBIOCatalyst Biosciences Inc
27/11/202321:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
23/11/202300:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CBIO

Your Recent History

LSE
POLX
Polarean Imaging
LSE
ZED
Zenova
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
PHE
Powerhouse Energy
LSE
SCLP
Scancell
LSE
LLOY
Lloyds Banking
LSE
AAZ
Anglo Asian Mining
LSE
KEFI
Kefi Gold And Copper
LSE
GGP
Greatland Gold
LSE
TERN
Tern
LSE
PHNX
Phoenix
LSE
AGL
Angle
LSE
RKH
Rockhopper Exploration
LSE
CYAN
Cyanconnode
LSE
NFDS
Northern Foods
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved